IRX Therapeutics Obtains $6,400,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7241d669-b519-4349-8fa7-21daf8232e0f - Date
11/11/2016 - Company Name
IRX Therapeutics - Mailing Address
140 West 57th Street New York, NY 10019 USA - Company Description
IRX Therapeutics’ mission is to discover and commercialize drugs that stimulate a coordinated TH1-specific cellular immune response to treat human diseases. This immune response is essential for the eradication of most viruses and tumors, and relies on the effective functioning of dendritic cells, macrophages, and T-cells. - Website
http://www.irxtherapeutics.com - Transaction Type
Debt - Transaction Amount
$6,400,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
